Type 2 Diabetes and Heart Failure: Challenges and Solutions

por Thomas, Merlin C.
Publicado 2016

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure

por Thomas, Merlin C
Publicado 2018

Forensic interrogation of diabetic endothelitis in cardiovascular diseases and clinical translation in heart failure

por Thomas, Merlin C, Iyngkaran, Pupalan
Publicado 2020

PPAR Agonists and Cardiovascular Disease in Diabetes

por Calkin, Anna C., Thomas, Merlin C.
Publicado 2008

Nutrient Sensing, Autophagy, and Diabetic Nephropathy

por Kume, Shinji, Thomas, Merlin C., Koya, Daisuke
Publicado 2012

The management of diabetes in indigenous Australians from primary care

por Thomas, Mark, Weekes, Andrew J, Thomas, Merlin C
Publicado 2007

Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709

por Ekinci, Elif I., MacIsaac, Richard J., Thomas, Merlin C., Jerums, George
Publicado 2011

Dietary intake and hospitalisation due to diabetic ketoacidosis and hypoglycaemia in individuals with type 1 diabetes

por Ahola, Aila J., Harjutsalo, Valma, Thomas, Merlin C., Forsblom, Carol, Groop, Per-Henrik
Publicado 2021

Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes

por Thomas, Merlin C, Moran, John, Mathew, Timothy H, Russ, Graeme R, Mohan Rao, M
Publicado 2000

Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment

por Thomas, Merlin C., Paldánius, Päivi M., Ayyagari, Rajeev, Ong, Siew Hwa, Groop, Per-Henrik
Publicado 2016

SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review

por Thomas, Merlin C, Neuen, Brendon L, Twigg, Stephen M, Cooper, Mark E, Badve, Sunil V
Publicado 2023

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy

por Herman-Edelstein, Michal, Thomas, Merlin C., Thallas-Bonke, Vicki, Saleem, Moin, Cooper, Mark E., Kantharidis, Phillip
Publicado 2011

Phase 4 Studies in Heart Failure - What is Done and What is Needed?

por Iyngkaran, Pupalan, Liew, Danny, McDonald, Peter, Thomas, Merlin C., Reid, Christopher, Chew, Derek, Hare, David L.
Publicado 2016

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

por Iyngkaran, Pupalan, Toukhsati, Samia R., Thomas, Merlin C., Jelinek, Michael V., Hare, David L., Horowitz, John D.
Publicado 2016

Does a Nephron Deficit Exacerbate the Renal and Cardiovascular Effects of Obesity?

por Gurusinghe, Seshini, Brown, Russell D., Cai, Xiaochu, Samuel, Chrishan S., Ricardo, Sharon D., Thomas, Merlin C., Kett, Michelle M.
Publicado 2013

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON]...

por Thomas, Merlin C., MacIsaac, Richard J., Jerums, George, Weekes, Andrew, Moran, John, Shaw, Jonathan E., Atkins, Robert C.
Publicado 2009

Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes

por Ekinci, Elif I., Clarke, Sophie, Thomas, Merlin C., Moran, John L., Cheong, Karey, MacIsaac, Richard J., Jerums, George
Publicado 2011

Contextualizing Genetics for Regional Heart Failure Care

por Iyngkaran, Pupalan, Thomas, Merlin C., Johnson, Renee, French, John, Ilton, Marcus, McDonald, Peter, Hare, David L., Fatkin, Diane
Publicado 2016

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice

por Tikellis, Chris, Robinson, Gardner N., Rosado, Carlos J., Batu, Duygu, Zuniga-Gutierrez, Maria A., Pickering, Raelene J., Thomas, Merlin C.
Publicado 2022

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes

por Gordin, Daniel, Soro-Paavonen, Aino, Thomas, Merlin C., Harjutsalo, Valma, Saraheimo, Markku, Bjerre, Mette, Forsblom, Carol, Flyvbjerg, Allan, Groop, Per-Henrik
Publicado 2013